Kardigan, Inc.
NASDAQ:KARDBiotechnology
+$0.77 today
- Market cap
- $1.10B
- Beta
- 0.00
Volume 0.55M
Average 5.84M
KARD Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Cash & Equivalents history
Currency unavailable · from the balance sheet
No Cash & Equivalents data reported for this period type.
Cash & Equivalents vs competitors
How KARD compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $424.15M USD | -24.8% | +1.6% | 60.2% | |
| Mar 2026 | $267.85M USD | — | — | 91.6% | |
| Jun 2026 | $255.27M USD | +240.6% | +23.2% | 13.3% | |
| Mar 2026 | $80.89M USD | +50.4% | +1.8% | 59.9% | |
| Mar 2026 | $49.57M USD | -32.5% | +168.5% | 28.6% | |
| — | — | — | — | — | |
| Peer median (excluding KARD) | — | +12.8% | +12.5% | 59.9% | |
Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Kardigan, Inc.
NASDAQ:KARD
Intrinsic Alpha fair value
Locked
Current Price
$12.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.